Pfizer CEO Albert Bourla received $24.3 million in total compensation for 2021
PUBLISHED FRI, MAR 18 202212:08 PM EDT. UPDATED FRI, MAR 18 20226:17 PM EDT
- Pfizer CEO Albert Bourla received $24.3 million in total compensation for 2021, a 15% increase over the prior year.
- Bourla’s total equity holdings, nearly 597,000 shares, are worth more than $32 million as of Thursday’s closing price $54.24.
- He’s entitled to a golden parachute of nearly $113 million, which was valued at end of December 2021.
Pfizer CEO Albert Bourla received $24.3 million in total compensation for 2021, a 15% increase over the prior year as the company’s full-year profit more than doubled with the successful rollout of its Covid vaccine.
Bourla took home a cash incentive of $8 million on top of his salary of $1.69 million. He also received stock and options totaling $13.2 million as well as $1.38 million in other compensation.
Bourla’s total equity holdings, nearly 597,000 shares, are worth more than $32 million as of Thursday’s closing price of $54.24. He’s also entitled to a golden parachute valued at nearly $113 million as of Dec. 31, if the company is sold and he loses his job as a result.
Bourla also received more than $336,000 for home security and more than $60,000 for air travel. His total salary is 262 times higher than the median compensation for a normal employee at Pfizer.
Pfizer booked a profit of nearly $22 billion in 2021, double the previous year as the company’s Covid vaccine became the most widely administered shot against in the U.S. and the European Union. Sales from Pfizer’s Covid vaccine totaled $36.7 billion in 2021, making up about 45% of its annual revenue of $81.2 billion. Pfizer is projecting another $32 billion in vaccine sales this year.
More Here:
